Premium
C4 article: Implications of COVID‐19 in transplantation
Author(s) -
Justin G. Aaron,
Lilian M. Abbo,
Felipe Alconchel,
Cristiano Amarelli,
Shweta Anjan,
Monica I. Ardura,
Marwan M. Azar,
Jamil Azzi,
John W. Baddley,
Wendy Balliet,
Maria Irene Bellini,
Emily A. Blumberg,
James A. Blumenthal,
Heather Bruschwein,
Lara DanzigerIsakov,
Valerie Demekhin,
Daniel E. Dulek,
Gustavo Fernandes Ferreira,
Alessandro Gambella,
Emmanouil Giorgakis,
Melissa R. Gitman,
Kristina Goff,
Michael Green,
Melissa A. Greenwald,
Jonathan Hand,
Marion HemmersbachMiller,
Atul Humar,
Michael G. Ison,
Andrés Jaramillo,
Michelle T Jesse,
Camille Nelson Kotton,
Kristin Kronsnoble,
Deepali Kumar,
Ricardo M. La Hoz,
Krista L. Lentine,
Santiago M. C. Lopez,
Benjamin A. Miko,
Sumit Mohan,
Naoka Murakami,
Patti Niles,
Annelise Nolan,
Camilla W. terah,
Jeong Mi Park,
Rebecca Pellett Madan,
Marcus R. Pereira,
Armelle Pérez Cortés Villalobos,
Nicole A. Pilch,
Lisa Potter,
James R. Rodrigue,
Mia Schmiedeskamp-Rahe,
Dhruva Sharma,
Amany Sholkamy,
Neeraj Singh,
Ekamol Tantisattamo,
Yasemin Tezer,
Nicole Theodoropoulos,
Crystal Truax,
Benito Valdepenas,
Deborah Verran,
Scott G. Westphal,
Kenneth J. Woodside
Publication year - 2021
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.16346
Subject(s) - medicine , intensive care medicine , transplantation , covid-19 , coronavirus , pandemic , disease , infectious disease (medical specialty) , virology , outbreak
A novel coronavirus has had global impact on individual health and health care delivery. In this C4 article, contributors discuss various aspects of transplantation including donor and recipient screening, management of infected patients, and prevention of coronavirus disease (COVID). Donor screening with SARS‐CoV‐2 nucleic acid testing (NAT) close to the time of procurement is recommended. Many programs are also screening all potential recipients at the time of admission. The management of COVID has evolved with remdesivir emerging as a new potential option for transplant recipients. Dexamethasone has also shown promise and convalescent plasma is under study. Prevention strategies for transplant candidates and recipients are paramount. Pediatric‐specific issues are also discussed. Strategies for the psychological well‐being of patients and providers are also imperative, in addition to future research priorities for transplantation.